underlying the altered migration of tubular epithelial cells that contributes to the inability of the aging kidney to repair following injury.
from ARF was 3 times as long in elderly (mean 67.1 years) compared to young (32.3 years); 32 versus 11.4 days, respectively. In meta-analysis of 17 studies it was found that a higher percentage of surviving elderly (>65 years) patients did not recover renal function as compared to younger patients [7] .
The cadherin gene superfamily encodes for transmembrane proteins that regulate calcium-dependent cell-cell adhesion [8] . A functional cadherin adhesion complex requires interaction with cytoplasmic proteins, the catenins. α-Catenin does not directly bind to cadherins, rather it interacts with the cytoplasmic domain of cadherins via β-or γ-catenin. p120 catenin binds to the cadherin cytoplasmic domain, and shares sequence homology with β-and γ-catenin, but does not bind α-catenin. There are several forms of α-catenin; α(E)-catenin is epithelial; α(N)-catenin is neuronal; α(T)-catenin is expressed in heart and testes, while α-catulin is a widely expressed catenin-like molecule [9] . It was long thought that α-catenin directly linked the cadherin/catenin complex to the cytoskeleton [10] ; as such, α-catenin was shown to interact with a variety of actin-binding proteins, including α-actinin, vinculin, and actin [11] [12] [13] . This paradigm was challenged by results demonstrating that α-catenin does not simultaneously interact with cadherins and the F-actin monomers, but regulates actin dynamics [14, 15] . However, cadherin adhesion clearly influences actin cytoskeleton organization and actin cytoskeleton integrity is necessary for cadherin-mediated adhesion [16] . Importantly, cadherin-independent functions of α-catenin are emerging [14, [17] [18] [19] [20] . In both Caenorhabditis elegans [18] and mouse keratinocytes [21] , the phenotype of α-catenin loss differs from that observed following cadherin loss. In cancers where both E-cadherin and α-catenin expression is lost, prognosis is worse than loss of the individual protein; this synergistic effect would not be predicted by disruption of cell adhesion alone [22, 23] .
While many studies have focused on tubular epithelial cell proliferation in repair [24, 25] , migration is a key component of renal repair following injury [26] . Previous studies in our laboratory have shown a loss of α-catenin expression in the proximal tubular epithelium in male Fischer 344 rats [27] . Given the role of α(E)-catenin in actin dynamics [14, 15] and the importance of actin in directed cell migration [28] , we hypothesized that loss of α(E)-catenin would decrease wound repair. In the current study, we generated NRK-52E cells with a stable knockdown of α(E)-catenin and investigated the wound repair phenotype.
Materials and Methods

Animals
Male Fischer 344 (F344) rats (4 and 24 months) were obtained from the NIA colony. On the day of the experiment, rats were anesthetized with a ketamine (80-120 mg/kg)/xylazine (5-10 mg/kg) intraperitoneal injection. Kidneys were collected and 1-mm sections were snap frozen in liquid nitrogen. All experimental procedures and animal care were approved by the University of Missouri Animal Care and Use Committee in accordance with NIH guidelines.
Cell Culture
Cells were grown in Dulbecco's modified Eagle medium nutrient mixture F-12 (DMEM/F12; 1: 1) containing L -glutamine and Hepes (Gibco, Cat. #2013-08) supplemented with 10% fetal bovine serum (FBS; Hyclone)/50 U/ml penicillin, 50 μg/ml streptomycin (Gibco) and incubated at 37 ° C in 5% CO 2 . Cells were harvested with TrypLE Express (Gibco, Cat. #12604-013) and pelleted at 300 g 5 min at room temperature.
Targeted and non-targeted clones for α(E)-catenin were generated by lentivirus-mediated shRNA by Sigma-Aldrich (St. Louis, Mo., USA). Single-cell clones of non-targeted and α(E)-catenintargeted cells were generated by growing the parental cell line to confluency, harvesting them with TrypLE Express and pelleting the cells at 1,000 g for 5 min at room temperature. Cells were then counted and a series of serial dilutions were seeded into a 96-well plate in DMEM/F12 containing 10% FBS and 5 μg/ml puromycin. On day 6 post-plating, wells were visualized on the microscope and any wells containing more than one colony of cells were discarded. Fresh media was put into each well every 3-5 days. Single-cell colonies were grown to confluence and passaged to larger plates. Non-targeted vector control cells (NT3) and α(E)-catenin knockdown cells -clonal line 2 (C2) and 4 (C4) cells -were grown in the presence of 5 μg/ml puromycin (Sigma-Aldrich) for lentivirus maintenance. The cell lines (NT3, C2 and C4) were used within 20 passages of establishing a clonal cell line.
Real-Time PCR
RNA was isolated using the RNeasy mini kit (Qiagen, Valencia, Calif., USA) or EZ Tissue/Cell Total RNA Miniprep Kit (EZ BioResearch, St. Louis, Mo., USA) with on-column DNase digestion from 5 × 10 6 to 1 × 10 7 cells. RNA concentration and quality was determined by spectrophotometry with NanoDrop 2000c (Thermo Scientific) and confirmed by agarose gel electrophoresis. cDNA was generated from 2 μg RNA using the High Capacity cDNA Synthesis Kit (Life Technologies, Carlsbad, Calif., USA) following the kit protocol. Quantitative PCR was performed in duplicate with 50 ng cDNA/reaction using TaqMan assays (Applied Biosystems) using SsoFast TM Probes Supermix with ROX (BioRad) and the CFX96 Touch system (Bio-Rad) with the following cycling conditions: 95 ° C for 20 s, then 40 times at 95 ° C for 1 s and 60 ° C for 20 s.
Commercially available TaqMan primer sets were used to assess α(E)-catenin (Rn01406769_mH), BMP-7 (Rn01528889_m1), BMPR1B (RN01500616_m1), Kcp (Rn01500616_m1), Noggin (Rn01467399_s1) and Sostdc1 (Rn00596672_m1). Relative quantitation was performed using the Pfaffl method [29] Western Blot Subconfluent cells were washed twice with ice-cold phosphatebuffered saline (PBS; Gibco, Life Technologies) and lysed with 10 m M Tris-1% SDS buffer with Halt TM Protease/Phosphatase inhibitor. Cells were scraped and incubated for 15 min at 4 ° C on a rocker. Cells were further disrupted by passing through a 20-gauge needle and spun at 12,000 g for 15 min at 4 ° C. Tissue lysates were isolated using a 10 m M Tris-1% SDS buffer supplemented with Halt TM Protease Inhibitor Cocktail (Thermo Fisher-Pierce, Rockford, Ill., USA). Protein concentration was determined by the BCA method using a commercially available kit (Thermo Fisher-Pierce).
The following antibodies were used: anti-α-catenin (monoclonal, clone 5) and anti-β-actin (monoclonal, clone AC-74; SigmaAldrich). Goat-anti-mouse HRP conjugate (Jackson ImmunoResearch Laboratories, West Grove, Pa., USA) was used at 1: 20,000 dilutions. Blots were developed using West Femto (Thermo Fisher-Pierce) and imaged using the ChemiDoc imaging system and quantitation performed using the ImageLab 3.0 software (BioRad, Hercules, Calif., USA).
Immunofluorescence
Cells were grown on 2-well glass chamber slides (Nuc Lab-Tek II; Thermo Scientific). Cells were washed with serum-free medium, fixed in 2% paraformaldehyde for 10 min, permeabilized with 1% Triton-X for 30 min, and blocked with Background Sniper (Biocare Medical, Concord, Calif., USA) for 1-2 h. Primary anti-phosphoSmad1/5/8 antibody (Cell Signaling, Beverly, Mass., USA, Cat. #9511) was isolated from BSA carrier using Protein A/G magnetic beads (Pierce, Cat. #88802), labeled with Alexa Fluor ® 488 5-TFP at pH 9.0 for 1 h at room temperature and isolated from free label using Protein A/G magnetic beads. Cells were incubated in directly labeled antibody overnight on rocker at 4 ° C. Cells were subsequently washed 3 times in PBS-T, shaken dry, and counterstained with Fluoroshield with DAPI (Sigma, Cat. #6057). Immediately prior to imaging, 1-2 drops of SlowFade Gold antifade reagent (Invitrogen, Cat. #S36937) were applied to the cells to further prevent bleaching. Cells were imaged on an Olympus IX51 microscope (Olympus, Center Valley, Pa., USA) under a 60 × oil immersion lens with a UC50 digital camera using cellSense software (Olympus) at the same exposure times. Original images (tiff or jpg files for merged images) were assembled into multipanel pictures and further enhancements were performed on all images simultaneously.
Wound Healing Assay
Cells were seeded in 6-well plates at 2 × 10 4 /cm 2 and grown to 80-90% confluence (approx. 24 h). A cross-scratch was made using a 200-μl Pipetman Tip. Media was removed and the wells washed twice with serum-free media. Cells were then incubated with or without serum + 5 μg/ml puromycin. For the mitomycin C assay, 5 μg/ml was added to serum-free-media + 5 μg/ml puromycin. Healing was visualized at 4× magnification over 24 h; at the end of the experiment, cells were stained with crystal violet. To quantify healing, the center area of the scratch was measured using the closed polygon tool (cellSense) and percent closure was determined.
In certain experiments, cells were exposed to 30 n M of a chemical BMP-7 type I receptor inhibitor was used, 6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-3-(pyridine-4-yl)pyrazolo[1,5-a]pyrimidine hydrochloride (DM-3189 LDN193189; BioVision, Milpitas, Calif., USA) [30] . In other experiments, exogenous recombinant human BMP-7 (100 ng/ml; ProSpec Bio, Rehovot, Israel) was added to cultures [31] .
Statistics
Results are expressed as mean ± SD. A one-or two-way (wound healing) analysis of variance (ANOVA) was performed followed by Student's t test using the statistical software GraphPad Prism 6 (GraphPad Software, La Jolla, Calif., USA). The differences were considered statistically significant when p < 0.05.
Results
In an effort to understand the impact of loss of α-catenin on tubular epithelial cells, stable knockdowns of α(E)-catenin were generated in NRK-52E cells. Several shRNA constructs targeting α(E)-catenin were designed and cell lines were generated that demonstrated varying levels of α(E)-catenin knockdown at the gene and protein level (data not shown). We generated clonal lines from vector control and α(E)-catenin knockdown cell lines by single-cell cloning; the NT3 (vector control) and C2 and C4 [targeted α(E)-catenin knockdown] cells. The C2 and C4 cells had significant knockdown of α(E)-catenin at the gene and protein level ( fig. 1 a and b, respectively) . α-Catenin expression at the plasma membrane was seen in NT3 cells, with almost a complete loss of staining in the C2 cell line ( fig. 1 c) . The knockdown of α(E)-catenin was stable for at least 20 passages (data not shown).
Wound healing was significantly inhibited in C2 cells in both serum and serum-free conditions ( fig. 2 a, b) . Interestingly, in C2 cells in serum or serum-free conditions, the wound was never completely healed, while domes of cells formed on the remaining monolayer in 10% serum. The fact that differences were seen in 10% serum suggested that the deficits in C2 cells might be due to disrupted migration. The hypothesis was supported by the finding that C2 cell proliferation was not decreased in either 10% serum or serum-free media at 12 and 24 h. When cells were incubated with mitomycin C to halt cell proliferation in the wound healing assay, a significant difference between NT3 and C2 cells was still observed ( fig. 2 c) . Interestingly, mitomycin C inhibited wound healing in both cell types, but C2 cells were only able to repair 60% of the wound as compared to NT3 cells in either control or mitomycin C conditions. These data indicate that alterations in migration underlie the decreased ability of C2 cells to repair. measurements over 3 independent experiments; each data point represents the mean ± SD. c Wound healing at 24 h in the presence of mitomycin C, which inhibits cell proliferation; each data point represents the mean ± SD from 2 independent experiments (n = 3 per experiment). * Indicates a significant difference from respective control. A complete loss of BMP-7 gene expression was seen in C2 cells as compared to the NT3 controls using RNA sequencing (data not shown). Quantitative PCR confirmed that BMP-7 expression was significantly reduced in both C2 and C4 cells ( fig. 3 a) . A correlation between the level of α(E)-catenin knockdown and expression of BMP-7 is seen, i.e. there is less α(E)-catenin and BMP-7 expression in C2 cells compared to C4. We also examined other components of the BMP-7 pathway in C2 cells. The expression of a BMP-7 receptor, BMPR1b [32] , and KCP, a BMP-7 agonist [33] , were unchanged in C2 cells ( fig. 3 b) . The expression of an endogenous BMP-7 antagonist, noggin [34] , was not significantly increased; however, the expression of Sostdc (USAG-1), another antagonist [35] , was significantly increased in C2 cells ( fig. 3 b) . Smad1, 5 and 8 are downstream mediators of BMP-7 signaling [36] , and there is a reduction in nuclear staining of phospho-Smad1/5/8 in C2 cells ( fig. 3 c) . Addition of exogenous BMP-7 to C2 cells significantly increased phosphoSmad1/5/8, suggesting that the downstream pathway for BMP-7 was intact in these cells, despite loss of BMP-7 expression ( fig. 3 c) . The gene expression of BMP-7 in kidney lysates from 24-month-old male Fischer 344 rats, which exhibit decreased α(E)-catenin expression in the proximal tubules [27] , is highly variable ( fig. 3 d) . Two of the 6 animals expressed BMP-7 at, or above, levels in young (4-month-old) controls, 2 had between 10 and 20% loss of BMP-7 expression, and 2 had between 20 and 35% loss of expression. When averaged, the difference between BMP-7 expression in young and aged kidney was not statistically significant, although there is a trend toward a decrease.
Given a role for BMP-7 in renal repair [37] , we examined the impact of BMP-7 on wound repair. Inhibition of BMP-7 in NT3 cells resulted in a complete loss of repair ( fig. 4 a) , demonstrating that BMP-7 is requisite and necessary for wound repair in this model. Addition of exogenous BMP-7 to C2 cells partially attenuated repair ( fig. 4 b) . Taken together, the data suggests that the α(E)-catenin regulates BMP-7 expression and there is a requirement for BMP-7 in repair.
Discussion
Classically, the function of α-catenin has been thought to be limited to its role in cadherin-mediated cell adhesion; however, cadherin-independent functions of α-catenin are emerging [17] [18] [19] [20] . For example, in several tumors the loss of α-catenin is a stronger prognostic factor for dedifferentiation [38] and invasion [38] [39] [40] as compared to E-cadherin loss. More specifically, increased sensitivity to growth factors, sustained activation of the ras-ERK pathway, increased NF-κB activity, and regulation of actin cytoskeleton dynamics are all regulated by α-catenin in a cadherin-independent manner [17] [18] [19] [20] . The loss of α-catenin expression leads to increased cell proliferation in tumor cells [41] , the mouse epidermis [21] and central nervous system [42] . This may involve aberrant activation of several pathways, including ras-ERK [21] and NF-κB [19] .
Loss of α(E)-catenin was associated with decreased ability to repair in a wound healing assay, due to alterations in cell migration. Our results are generally consistent with the phenotype of α(E)-catenin knockdown reported in MDCK cells where α(E)-catenin knockdown was associated with altered cell morphology and disrupted cell-cell adhesion; however, in the wound healing assay the knockdown cells repaired at the same rate as control cells [14] . While the migration rate was increased following α(E)-catenin knockdown in MDCK cells, migration was not coordinated and it was suggested that migratory deficit in α(E)-catenin knockdown cells is due to decreased cadherin-mediated cell adhesion [14] . A critical role for BMP-7 in kidney development has been established [43] . In addition, it may be renoprotective against both acute [44] and chronic kidney injury [33] . With respect to chronic kidney disease, BMP-7 is suggested to have antifibrotic effects, in part by attenuating TGF-β 1 signaling [45] . BMP-7 signaling is tightly regulated at several levels, including expression and modulation of the pathway by both endogenous agonists and antagonists. In both normal mouse [31] and human kidneys [46] , BMP-7 is predominantly localized to the distal segments of the nephron and not expressed in proximal tubules. However, BMP-7 expression is dramatically upregulated in the proximal tubules after injury [47, 48] . This could explain the lack of an effect of aging on overall BMP-7 gene expression as the age-dependent loss of α-catenin is seen in the proximal tubules [27] . The regulation of BMP-7 expression is not completely defined. Cell culture studies have shown that protein kinase C (PKC) regulates BMP-7 expression [49] . A reporter construct using a 4.6-kb portion of the human BMP-7 promoter demonstrates that both retinoic acid and prostaglandin E 2 increase BMP-7 expression [50] . Futures studies will focus on identifying the pathway linking α(E)-catenin and BMP-7 regulation.
BMP-7 mediates its effects by binding to receptors, the bone morphogenic protein receptors IA and IB, bone morphogenic protein receptor II, and the activin type I receptor, which have serine-threonine kinase activity [32] . These receptors activate Smad transcription factors, including Smad1/5/8 [36] . BMP-7 signaling is also modulated by a number of endogenous antagonists including Sostdc1 and noggin [34, 35] , as well as agonists, including KCP [33] . This regulation adds further cellular specificity and complexity to BMP-7 signaling. Although knockdown of α(E)-catenin decreased increased expression of Sostdc1, the signaling pathway remained intact and stimulable in C2 cells as demonstrated by the finding that exogenous BMP-7 elicited Smad activation. Specific targets of BMP-7 have yet to be identified in C2 cells, future studies will focus on the mechanism(s) by which BMP-7 stimulates repair in the NRK-52E model.
A role for BMP-7 in the regulation of migration has been established. The migration of metastatic breast cancer cells (4T1E/M3) was inhibited by either a BMP-7 neutralizing antibody, or miR RNAi knockdown of BMP-7 [51] . BMP-7 also regulated cell migration in human bone marrow mesenchymal stem cells [52] . Interestingly, the regulation of migration by BMP-7 may involve remodeling of the actin cytoskeleton via Rho-ROCK1 [53] . Given the relationship between α(E)-catenin and actin dynamics, an intriguing possibility is that the decreased expression of BMP-7 is important in the disruption of the actin cytoskeleton seen in C2 cells (data not shown).
These data demonstrate that loss of α(E)-catenin expression leads to decreased BMP-7 expression, and decreased repair. Exogenous BMP-7 is able to partially rescue this repair deficit and suggest that an α(E)-catenin-BMP-7 pathway may be important in tubular epithelial repair.
